Clover Health Investments, Corp.
Clover Health Investments, Corp.（CLOV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
clov · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Hold
9 位分析师
共识
评级分布
12 个月目标价
High
$4.20
Consensus
$4.20
+8.0% upside
Low
$4.20
Median: $4.2 · Last Close: $3.89
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.05 | ↑ 4.12% |
1-day model range: $4.01–$4.09. Peak: $4.09 (+4.12%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | +41.2% |
| 2028 | $7 | +76.1% |
| 2029 | $8 | +102.2% |
| 2030 | $9 | +120.2% |
| 2031 | — | +132.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLOV · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-20 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-05 | Leerink Partners | Maintains | Market Perform→Market Perform |
| 2026-01-20 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-06 | UBS | Maintains | Neutral→Neutral |
| 2025-03-03 | Canaccord Genuity | Maintains | Buy→Buy |
| 2023-08-11 | Citigroup | Maintains | Neutral→Neutral |
| 2023-03-06 | Credit Suisse | Maintains | Underperform→Underperform |
Wall Street analysts have recently issued updated ratings on Clover Health Investments, Corp. (CLOV) stock. Of the recent 24 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover CLOV.
分析师推荐趋势
CLOV analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2.9B
↓ 20.6% YoY
Revenue Next Year
$3.3B
↑ 14.2% YoY
EPS This Year
$0.04
EPS Next Year
$0.05
↑ 30.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLOV EPS of $0.04 for the current fiscal year, based on estimates from 1 analysts. The CLOV revenue forecast is $2.9B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CLOV 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CLOV 的共识目标价为 $4.20（+8.0% 上行空间），分析师共识为 Hold。
CLOV 的短期预测（明日）为 $4.05（+4.12%）。 CLOV 对 2027 年的股价预测均值为 $5。 CLOV 对 2030 年的预测区间为 $8–$9。
Clover Health Investments, Corp. 在 NASDAQ 上市，代码 CLOV。CLOV 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 11% 对应 Hold 共识。
常见问题
CLOV 预测 · 8 个问题根据 9 位华尔街分析师，CLOV 的 12 个月平均目标价为 $4.20，最高 $4.20、最低 $4.20。若有图表，中位目标价可在上方查看。相对当前价 $3.89，隐含约 +8.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.